워크원오원 secures seed investment from MYSC and TIPS selection to enhance its AI X-ray interpretation solutions and expand globally.

Target Information

워크원오원 (WorkOneO1) is a startup specializing in the development of AI-based solutions for assisting in the interpretation of musculoskeletal X-rays. The company has recently announced a seed investment from MYSC (엠와이소셜컴퍼니) and has been selected for the TIPS (Technology Investment Program for Startups) program. While the specifics of the investment amount remain undisclosed, the funding is expected to facilitate the enhancement of their annotation technology and accelerate their expansion into global markets. The selection for TIPS will further expedite the refinement of core technologies, including the Large Musculoskeletal Model (LMSM), advancements in self-learning driven by clinical data, and the sophistication of a global SaaS architecture.

Industry Overview in South Korea

The digital healthcare sector in South Korea is experiencing significant growth, driven by the increasing demand for innovative medical technologies and solutions. The country faces a critical shortage of radiologists, particularly in the field of musculoskeletal imaging, which has intensified the need for AI-assisted diagnostic tools. Startups like 워크원오원 are at the forefront of addressing this gap, leveraging artificial intelligence to automate the analysis of X-ray images, thus improving productivity and accuracy in medical diagnoses.

South Korea's healthcare system is largely advanced, yet it continues to encounter disparities in access to specialized medical services. The integration of AI into healthcare is aimed at bridging these gaps—enhancing service quality across variou

View Source

Similar Deals

MYSC 티립스 (Tips)

2025

Seed Stage Biotechnology & Medical Research (NEC) South Korea
카카오벤처스 플로우닉스

2023

Seed Stage Bio Diagnostics & Testing South Korea
Vorwerk Ventures Carelane

2025

Seed Stage Biotechnology & Medical Research (NEC) Germany
启明创投 蔚程医药有限公司

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) China
SC Launch Inc. NeuroQuest

2025

Seed Stage In-Vivo Diagnostic & Testing Substances United States of America

MYSC

invested in

워크원오원

in 2025

in a Seed Stage deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert